April 24, 2024
Loading...
You are here:  Home  >  'Amgen'  -  Page 64
Latest

The high-tech plumber: Sani-Tech West keeps big bio names flowing

By   /  Friday, October 19th, 2012  /  Features, Technology  /  Comments Off on The high-tech plumber: Sani-Tech West keeps big bio names flowing

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Editorial: Following-up on Congressional insider trades

By   /  Friday, August 17th, 2012  /  Editorials, Opinion  /  Comments Off on Editorial: Following-up on Congressional insider trades

In late July, our news pages carried an article  about a series of potentially favorable stock trades in shares of Thousand Oaks-based Amgen that may have benefited the wealthy wife of U.S. Sen. John Kerry. Disclosure of the trades, made in 2007 on behalf of a trust that benefits Teresa Heinz Kerry, would not have Read More →

Latest

Newsom talks business recruitment at Amgen HQ

By   /  Friday, July 27th, 2012  /  Latest news  /  Comments Off on Newsom talks business recruitment at Amgen HQ

With about 100 Ventura County leaders gathered at the sprawling Amgen campus in Thousand Oaks, Lt. Gov. Gavin Newsom made a rare appearance in the Tri-Counties on July 27 to promote a new “Gold Team” effort to recruit businesses to California. Taking a stab at bi-partisanship, he appeared at the podium with Republican Assemblyman Jeff Read More →

Latest

Analysis: John Kerry trades on Amgen show loophole in new law

By   /  Friday, July 27th, 2012  /  Banking & Finance, Law & Goverment, Technology, Top Stories, Tri-County Public Companies  /  1 Comment

By Julian Moore, Special to the Business Times, on July 27, 2012 In August, stock sales by members of Congress and thousands of federal employees will get new scrutiny under the STOCK Act, a law passed in April to combat insider trading among government officials. But a Business Times examination of the timing of the Read More →

Latest

Amgen Q2 earnings up 8 percent

By   /  Thursday, July 26th, 2012  /  Latest news  /  Comments Off on Amgen Q2 earnings up 8 percent

[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”26-01-2012″ enddate=”26-07-2012″ width=”300″ height=”245″] Amgen’s earnings beat market expectations in the second quarter and rose 8.2 percent, the Thousand Oaks-based biotech giant said in a July 26 report. The company reported a profit of $1.27 billion, or $1.61 a share, up from $1.17 billion, or $1.25 a share,  a year Read More →

Latest

Whistleblower makes DaVita cough up $55M

By   /  Friday, July 13th, 2012  /  Top Stories, Tri-County Public Companies  /  Comments Off on Whistleblower makes DaVita cough up $55M

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen case puts class action rules to test

By   /  Friday, June 15th, 2012  /  Banking & Finance, Law & Goverment, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen case puts class action rules to test

Thousand Oaks-based Amgen is set to argue a case before the U.S. Supreme Court that could make it harder for shareholders to band together and sue publicly traded companies over public comments made by top officials. The court agreed to hear a stock-fraud case this fall between Amgen and Connecticut Retirement Plans and Trust Funds, Read More →